Efficacy of monteplase for submacular hemorrhage

Efficacy of monteplase for submacular hemorrhage - Monteplase for submacular hemorrhage

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017174

Enrollment

Registered

2015-04-20

Start date

2015-04-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

submacular hemorrhage

Interventions

Intravitreal injection of monteplase

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who has submacular hemorrhage are included.

Exclusion criteria

Exclusion criteria: Patients who has a severe heart disease, arrhythmia, renal disorder, and who are pregnant are excluded.

Design outcomes

Primary

Measure	Time frame
fundus findings	—

Countries

Japan

Contacts

Public ContactYoko Ozawa

Keio University School of Medicine, Department of Ophthalmology

ozawa@a5.keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026